Dakota Johnson recalled how she had to forge her own acting career after high school when her dad cut her off as part of an ...

On Sunday, U.S. President Donald Trump changed that precedent, announcing that he would sign an executive order Monday to ...

One possible explanation for the gap is the availability of highly efficacious CAR-T therapies in the U.S. and Europe serving as later-line therapies to improve survival outcomes. The FDA has also ...

The US FDA has approved Johnson & Johnson's drug to treat patients aged 12 years and older with an immune-mediated disorder ...

The U.S. Food and Drug Administration on Wednesday approved Johnson & Johnson's drug to treat a type of muscle-weakening ...

BofA Securities 2025 Healthcare Conference May 13, 2025 1:40 PM ETCompany ParticipantsJohn Reed - Executive Vice ...

The Hatch-Waxman Act of 1984—which lowered barriers for smaller drug companies to introduce nonbrand versions of drugs whose patents had expired—was negotiated just as bigs like Johnson ...

The Food and Drug Administration should look for ways to streamline regulations on new U.S. drug manufacturing facilities to ...

Dakota Johnson is the daughter and granddaughter of Hollywood royalty--and just one of seven brothers and sisters in her ...

The drug also showed a favorable safety profile, with adverse events comparable to placebo and no new safety signals observed. Liza O’Dowd, MD, of Johnson & Johnson, emphasized the potential of ...

First and only FcRn blocker approved in anti-AChR and anti-MuSK antibody positive adults and pediatric gMG patients aged 12 and older IMAAVY delivered rapid and substantial reduction in ...